Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Sergey Nikolaev

Showing results (31-40 of 51) with videos related to

Pageof 6
Sort By:
Nature Communications|December 5, 2014
Extrachromosomal driver mutations in glioblastoma and low-grade gliomaSergey Nikolaev, Federico Santoni, Marco Garieri, et al.
International Journal of Molecular Sciences|May 13, 2023
The <i>CFTR</i> Gene Germline Heterozygous Pathogenic Variants in Russian Patients with Malignant Neoplasms and Healthy Carriers: 11,800 WGS ResultsMaria Makarova, Marina Nemtsova, Anastasiia Danishevich, et al.
Cancers|January 11, 2024
Novel Pathogenic Variants in Hereditary Cancer Syndromes in a Highly Heterogeneous Cohort of Patients: Insights from Multigene AnalysisAirat Bilyalov, Anastasiia Danishevich, Sergey Nikolaev, et al.
Transplantation|February 25, 2020
Immunologic Clearance of a BK Virus-associated Metastatic Renal Allograft CarcinomaRaphael P H Meier, Yannick D Muller, Pierre-Yves Dietrich, et al.
Biomedicines|December 23, 2023
<i>CDKN2A</i> Gene Mutations: Implications for Hereditary Cancer SyndromesAnastasiia Danishevich, Airat Bilyalov, Sergey Nikolaev, et al.
Journal for Immunotherapy of Cancer|June 23, 2026
VEGF-A blockade overcomes liver metastases resistance to chemoimmunotherapy in patients with advanced non-squamous NSCLCMatthieu Roulleaux-Dugage, Andrey Yurchenko, Sergey Nikolaev, et al.
Nature Communications|June 15, 2026
TASP1-mediated cleavage of REV3L enhances the activity of DNA polymerase ζ in mammalian cellsJordane Goulas, Basile Guignier, Barbara Ben Yamin, et al.
Journal for Immunotherapy of Cancer|July 27, 2022
Overcoming resistance to αPD-1 of MMR-deficient tumors with high tumor-induced neutrophils levels by combination of αCTLA-4 and αPD-1 blockersLaetitia Nebot-Bral, Antoine Hollebecque, Andrey A Yurchenko, et al.
The EMBO Journal|September 17, 2021
DNA polymerase zeta contributes to heterochromatin replication to prevent genome instabilityBarbara Ben Yamin, Sana Ahmed-Seghir, Junya Tomida, et al.
Hereditary Cancer in Clinical Practice|February 18, 2025
Assessing germline TP53 mutations in cancer patients: insights into Li-Fraumeni syndrome and genetic testing guidelinesAnastasiia Danishevich, Daria Fedorova, Natalia Bodunova, et al.
Pageof 6

Showing results (31-40 of 51) with videos related to

Sort By:
Pageof 6
Nature Communications|December 5, 2014
Extrachromosomal driver mutations in glioblastoma and low-grade gliomaSergey Nikolaev, Federico Santoni, Marco Garieri, et al.
International Journal of Molecular Sciences|May 13, 2023
The <i>CFTR</i> Gene Germline Heterozygous Pathogenic Variants in Russian Patients with Malignant Neoplasms and Healthy Carriers: 11,800 WGS ResultsMaria Makarova, Marina Nemtsova, Anastasiia Danishevich, et al.
Cancers|January 11, 2024
Novel Pathogenic Variants in Hereditary Cancer Syndromes in a Highly Heterogeneous Cohort of Patients: Insights from Multigene AnalysisAirat Bilyalov, Anastasiia Danishevich, Sergey Nikolaev, et al.
Transplantation|February 25, 2020
Immunologic Clearance of a BK Virus-associated Metastatic Renal Allograft CarcinomaRaphael P H Meier, Yannick D Muller, Pierre-Yves Dietrich, et al.
Biomedicines|December 23, 2023
<i>CDKN2A</i> Gene Mutations: Implications for Hereditary Cancer SyndromesAnastasiia Danishevich, Airat Bilyalov, Sergey Nikolaev, et al.
Journal for Immunotherapy of Cancer|June 23, 2026
VEGF-A blockade overcomes liver metastases resistance to chemoimmunotherapy in patients with advanced non-squamous NSCLCMatthieu Roulleaux-Dugage, Andrey Yurchenko, Sergey Nikolaev, et al.
Nature Communications|June 15, 2026
TASP1-mediated cleavage of REV3L enhances the activity of DNA polymerase ζ in mammalian cellsJordane Goulas, Basile Guignier, Barbara Ben Yamin, et al.
Journal for Immunotherapy of Cancer|July 27, 2022
Overcoming resistance to αPD-1 of MMR-deficient tumors with high tumor-induced neutrophils levels by combination of αCTLA-4 and αPD-1 blockersLaetitia Nebot-Bral, Antoine Hollebecque, Andrey A Yurchenko, et al.
The EMBO Journal|September 17, 2021
DNA polymerase zeta contributes to heterochromatin replication to prevent genome instabilityBarbara Ben Yamin, Sana Ahmed-Seghir, Junya Tomida, et al.
Hereditary Cancer in Clinical Practice|February 18, 2025
Assessing germline TP53 mutations in cancer patients: insights into Li-Fraumeni syndrome and genetic testing guidelinesAnastasiia Danishevich, Daria Fedorova, Natalia Bodunova, et al.
Pageof 6